Xiamen INNOBIOMAX Biotechnology Co., Ltd.

INNOBIOMAX is the core raw materials subsidiary of WANTAI BioPharm (Stock Code: 603392.SH). The company originated from diagnostic division of Xiamen WANTAI group in 2010. Leveraging our joint Industry-Academia platform with Xiamen University and driven by our core philosophy of "First Class Quality, First Class Innovation.", INNOBIOMAX builds upon over a decade of deep IVD expertise from WANTAI BioPharm and INNODX. We focus on the independent R&D, large-scale production, and commercial supply of bio-active raw materials. Today, we have been delivering stable and high-performance raw material solutions to WANTAI BioPharm subsidiaries and other IVD manufacturers, widely used in IVD kits, quality controls and serum panels production.